The Hippo superhighway: Signaling crossroads converging on the Hippo/Yap pathway in stem cells and development

Current Opinion in Cell Biology

Volumn 25, Issue 2, 2013, Pages 247-253

  Barry, Evan R ^a,b,c   Camargo, Fernando D ^a,b,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b Harvard University   (United States)

^c HARVARD STEM CELL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; TAZ PROTEIN; UNCLASSIFIED DRUG; YAP PROTEIN; DROSOPHILA PROTEIN; NUCLEAR PROTEIN; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE; TRANSACTIVATOR PROTEIN; WNT PROTEIN; YORKIE PROTEIN, DROSOPHILA;

ARTICLE; CANCER STEM CELL; CELL COMMUNICATION AND CELL CONTACT; CELL FATE; CELL GROWTH; DEVELOPMENTAL BIOLOGY; EMBRYO DEVELOPMENT; EPIDERMIS; GENE EXPRESSION; HIPPO PROTEIN; HIPPO SIGNALING PATHWAY; INTESTINE CELL; MECHANOTRANSDUCTION; MOLECULAR INTERACTION; NUCLEAR REPROGRAMMING; ORGAN SIZE; PHOSPHORYLATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEM CELL; ANIMAL; CYTOLOGY; HUMAN; INTESTINE; METABOLISM; PATHOLOGY; REVIEW;

ANIMALS; DROSOPHILA PROTEINS; EMBRYONIC DEVELOPMENT; EPIDERMIS; HUMANS; INTESTINES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOPLASTIC STEM CELLS; NUCLEAR PROTEINS; ORGAN SIZE; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; STEM CELLS; TRANS-ACTIVATORS; WNT PROTEINS;

MLCS; MLOWN;

EID: 84877930326     PISSN: 09550674     EISSN: 18790410     Source Type: Journal    
DOI: 10.1016/j.ceb.2012.12.006     Document Type: Review

References (57)

1. Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA, Gayyed MF, Anders RA, Maitra A, Pan D: Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 2007, 130:1120-1133.
2. Metcalf D: Restricted growth capacity of multiple spleen grafts. Transplantation 1964, 2:387-392.
3. Kam I, Lynch S, Svanas G, Todo S, Polimeno L, Francavilla A, Penkrot RJ, Takaya S, Ericzon BG, Starzl TE et al.: Evidence that host size determines liver size: studies in dogs receiving orthotopic liver transplants. Hepatology 1987, 7:362-366.
4. Starzl TE, Fung J, Tzakis A, Todo S, Demetris AJ, Marino IR, Doyle H, Zeevi A, Warty V, Michaels M et al.: Baboon-to-human liver transplantation. Lancet 1993, 341:65-71.
5. McPherron AC, Lee SJ: Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci USA 1997, 94:12457-12461.
6. Camargo FD, Gokhale S, Johnnidis JB, Fu D, Bell GW, Jaenisch R, Brummelkamp TR: YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol 2007, 17:2054-2060.
7. Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J, Xie J, Ikenoue T, Yu J, Li L et al.: Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 2007, 21:2747-2761.
8. Schlegelmilch K, Mohseni M, Kirak O, Pruszak J, Rodriguez JR, Zhou D, Kreger BT, Vasioukhin V, Avruch J, Brummelkamp TR et al.: Yap1 acts downstream of alpha-catenin to control epidermal proliferation. Cell 2011, 144:782-795.
9. Silvis MR, Kreger BT, Lien WH, Klezovitch O, Rudakova GM, Camargo FD, Lantz DM, Seykora JT, Vasioukhin V: {alpha}- Catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1. Sci Signal 2011, 4:ra33.
10. Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, Zanconato F, Le Digabel J, Forcato M, Bicciato S et al.: Role of YAP/TAZ in mechanotransduction. Nature 2011, 474:179-183.
11. Yu FX, Zhao B, Panupinthu N, Jewell JL, Lian I, Wang LH, Zhao J, Yuan H, Tumaneng K, Li H et al.: Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 2012, 150:780-791.
12. Ramos A, Camargo FD: The Hippo signaling pathway and stem cell biology. Trends Cell Biol 2012, 22:339-346.
13. Zhao B, Tumaneng K, Guan KL: The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat Cell Biol 2011, 13:877-883.
14. Zhang N, Bai H, David KK, Dong J, Zheng Y, Cai J, Giovannini M, Liu P, Anders RA, Pan D: The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. Dev Cell 2010, 19:27-38.
15. Zhou D, Conrad C, Xia F, Park JS, Payer B, Yin Y, Lauwers GY, Thasler W, Lee JT, Avruch J et al.: Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell 2009, 16:425-438.
16. Lee KP, Lee JH, Kim TS, Kim TH, Park HD, Byun JS, Kim MC, Jeong WI, Calvisi DF, Kim JM et al.: The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. Proc Natl Acad Sci USA 2010, 107:8248-8253.
17. Lu L, Li Y, Kim SM, Bossuyt W, Liu P, Qiu Q, Wang Y, Halder G, Finegold MJ, Lee JS et al.: Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc Natl Acad Sci USA 2010, 107:1437-1442.
18. Morin-Kensicki EM, Boone BN, Howell M, Stonebraker JR, Teed J, Alb JG, Magnuson TR, O'Neal W, Milgram SL: Defects in yolk sac vasculogenesis, chorioallantoic fusion, and embryonic axis elongation in mice with targeted disruption of Yap65. Mol Cell Biol 2006, 26:77-87.
19. Hossain Z, Ali SM, Ko HL, Xu J, Ng CP, Guo K, Qi Z, Ponniah S, Hong W, Hunziker W: Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1. Proc Natl Acad Sci USA 2007, 104:1631-1636.
20. Yagi R, Kohn MJ, Karavanova I, Kaneko KJ, Vullhorst D, DePamphilis ML, Buonanno A: Transcription factor TEAD4 specifies the trophectoderm lineage at the beginning of mammalian development. Development 2007, 134:3827-3836.
21. Nishioka N, Inoue K, Adachi K, Kiyonari H, Ota M, Ralston A, Yabuta N, Hirahara S, Stephenson RO, Ogonuki N et al.: The Hippo signaling pathway components Lats and Yap pattern Tead4 activity to distinguish mouse trophectoderm from inner cell mass. Dev Cell 2009, 16:398-410.
22. Lian I, Kim J, Okazawa H, Zhao J, Zhao B, Yu J, Chinnaiyan A, Israel MA, Goldstein LS, Abujarour R et al.: The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. Genes Dev 2010, 24:1106-1118.
23. Tamm C, Bower N, Anneren C: Regulation of mouse embryonic stem cell self-renewal by a Yes-YAP-TEAD2 signaling pathway downstream of LIF. J Cell Sci 2011, 124:1136-1144.
24. Qin H, Blaschke K, Wei G, Ohi Y, Blouin L, Qi Z, Yu J, Yeh RF, Hebrok M, Ramalho-Santos M: Transcriptional analysis of pluripotency reveals the Hippo pathway as a barrier to reprogramming. Hum Mol Genet 2012, 21:2054-2067.
25. Kuhnert F, Davis CR, Wang HT, Chu P, Lee M, Yuan J, Nusse R, Kuo CJ: Essential requirement for Wnt signaling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf-1. Proc Natl Acad Sci USA 2004, 101:266-271.
26. Pinto D, Gregorieff A, Begthel H, Clevers H: Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes Dev 2003, 17:1709-1713.
27. van der Flier LG, Clevers H: Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol 2009, 71:241-260.
28. Clevers H: Wnt/beta-catenin signaling in development and disease. Cell 2006, 127:469-480.
29. Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, van den Born M, Danenberg E, Clarke AR, Sansom OJ, Clevers H: Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009, 457:608-611.
30. Karpowicz P, Perez J, Perrimon N: The Hippo tumor suppressor pathway regulates intestinal stem cell regeneration. Development 2010, 137:4135-4145.
31. Poernbacher I, Baumgartner R, Marada SK, Edwards K, Stocker H: Drosophila Pez acts in Hippo signaling to restrict intestinal stem cell proliferation. Curr Biol 2012, 22:389-396.
32. Ren F, Wang B, Yue T, Yun EY, Ip YT, Jiang J: Hippo signaling regulates Drosophila intestine stem cell proliferation through multiple pathways. Proc Natl Acad Sci USA 2010, 107:21064- 21069.
33. Shaw RL, Kohlmaier A, Polesello C, Veelken C, Edgar BA, Tapon N: The Hippo pathway regulates intestinal stem cell proliferation during Drosophila adult midgut regeneration. Development 2010, 137:4147-4158.
34. Staley BK, Irvine K.D.: Warts and Yorkie mediate intestinal regeneration by influencing stem cell proliferation. Curr Biol 2010, 20:1580-1587.
35. Shao J, Sheng H: Amphiregulin promotes intestinal epithelial regeneration: roles of intestinal subepithelial myofibroblasts. Endocrinology 2010, 151:3728-3737.
36. Zhang J, Ji JY, Yu M, Overholtzer M, Smolen GA, Wang R, Brugge JS, Dyson NJ, Haber DA: YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway. Nat Cell Biol 2009, 11:1444-1450.
37. Cai J, Zhang N, Zheng Y, de Wilde RF, Maitra A, Pan D: The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes Dev 2010, 24:2383- 2388.
38. Zhou D, Zhang Y, Wu H, Barry E, Yin Y, Lawrence E, Dawson D, Willis JE, Markowitz SD, Camargo FD et al.: Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proc Natl Acad Sci USA 2011, 108:E1312- E1320.
39. Andreu P, Peignon G, Slomianny C, Taketo MM, Colnot S, Robine S, Lamarque D, Laurent-Puig P, Perret C, Romagnolo B: A genetic study of the role of the Wnt/beta-catenin signalling in Paneth cell differentiation. Dev Biol 2008, 324:288-296.
40. Konsavage WJ, Kyler SL, Rennoll SA, Jin G, Yochum GS: Wnt/bcatenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells. J Biol Chem 2012, 287:11730-11739.
41. Barry ER, Morikawa T, Butler BL, Shrestha K, de la Rosa R, Yan KS, Fuchs CS, Magness ST, Smits R, Ogino S et al.: Restriction of intestinal stem cell expansion and the regenerative response by YAP. Nature 2013, 493:106-110.
42. Bottomly D, Kyler SL, McWeeney SK, Yochum GS: Identification of {beta}-catenin binding regions in colon cancer cells using ChIP-Seq. Nucleic Acids Res 2010, 38:5735-5745.
43. Imajo M, Miyatake K, Iimura A, Miyamoto A, Nishida E: A molecular mechanism that links Hippo signalling to the inhibition of Wnt/beta-catenin signalling. EMBO J 2012, 31:1109-1122.
44. Varelas X, Miller BW, Sopko R, Song S, Gregorieff A, Fellouse FA, Sakuma R, Pawson T, Hunziker W, McNeill H et al.: The Hippo pathway regulates Wnt/beta-catenin signaling. Dev Cell 2010, 18:579-591.
45. Gan XQ, Wang JY, Xi Y, Wu ZL, Li YP, Li L: Nuclear Dvl, c-Jun, betacatenin, and TCF form a complex leading to stabilization of beta-catenin-TCF interaction. J Cell Biol 2008, 180:1087-1100.
46. Itoh K, Brott BK, Bae GU, Ratcliffe MJ, Sokol SY: Nuclear localization is required for Dishevelled function in Wnt/betacatenin signaling. J Biol 2005, 4:3.
47. The Cancer Genome Atlas Network: Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012, 487:330-337.
48. Xie H, Tranguch S, Jia X, Zhang H, Das SK, Dey SK, Kuo CJ, Wang H: Inactivation of nuclear Wnt-beta-catenin signaling limits blastocyst competency for implantation. Development 2008, 135:717-727.
49. Hammond NL, Headon DJ, Dixon MJ: The cell cycle regulator protein 14-3-3sigma is essential for hair follicle integrity and epidermal homeostasis. J Invest Dermatol 2012, 132:1543-1553.
50. Heallen T, Zhang M, Wang J, Bonilla-Claudio M, Klysik E, Johnson RL, Martin JF: Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science 2011, 332:458-461.
51. Xin M, Kim Y, Sutherland LB, Qi X, McAnally J, Schwartz RJ, Richardson JA, Bassel-Duby R, Olson EN: Regulation of insulinlike growth factor signaling by yap governs cardiomyocyte proliferation and embryonic heart size. Sci Signal 2011, 4:ra70.
52. von Gise A, Lin Z, Schlegelmilch K, Honor LB, Pan GM, Buck JN, Ma Q, Ishiwata T, Zhou B, Camargo FD et al.: YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy. Proc Natl Acad Sci USA 2012, 109:2394-2399.
53. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ: Efficient tumour formation by single human melanoma cells. Nature 2008, 456:593-598.
54. Cordenonsi M, Zanconato F, Azzolin L, Forcato M, Rosato A, Frasson C, Inui M, Montagner M, Parenti AR, Poletti A et al.: The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell 2011, 147:759-772.
55. Vermeulen L, De Sousa EMF, van der Heijden M, Cameron K, de Jong JH, Borovski T, Tuynman JB, Todaro M, Merz C, Rodermond H et al.: Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 2010, 12:468-476.
56. Schepers AG, Snippert HJ, Stange DE, van den Born M, van Es JH, van de Wetering M, Clevers H: Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science 2012, 337:730-735.
57. Jansson L, Larsson J: Normal hematopoietic stem cell function in mice with enforced expression of the Hippo signaling effector YAP1. PLoS ONE 2012, 7:e32013.